| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8458838 | Radiotherapy and Oncology | 2018 | 8 Pages |
Abstract
This study demonstrates that extracranial RT plays an increasing role in the management of metastatic melanoma patients in the era of immunotherapy. The site and the timing of RT may have important interaction with immunotherapy, and need to be carefully considered in future clinical trials.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Prashant Gabani, Clifford G. Robinson, George Ansstas, Tanner M. Johanns, Jiayi Huang,